Dominic Piscitelli net worth and biography

Dominic Piscitelli Biography and Net Worth

Mr. Piscitelli brings to ORIC^® 20 years of industry experience, including debt and equity financings, in-licensing transactions, acquisitions, marketing partnerships and commercial product launches (XTANDI^® and Tarceva^®). Prior to joining ORIC, Mr. Piscitelli was CFO of AnaptysBio, a NASDAQ-listed biotechnology company, where he helped raise over $500 million in an IPO and follow-on financings. Prior to AnaptysBio, Mr. Piscitelli was Vice President of Finance, Strategy and Investor Relations at Medivation and played a key role in its acquisition by Pfizer. Previously, he served as Senior Director of Collaborations and Operations Finance at Astellas Pharma. Prior to that, Mr. Piscitelli served in various roles of increasing responsibility culminating as the Vice President, Treasury & Management Finance at OSI Pharmaceuticals, and played a significant role in their acquisition by Astellas. Mr. Piscitelli began his career with KPMG and is a certified public accountant. He earned a bachelor’s degree in accounting and an MBA from Hofstra University. He currently serves on the board of directors of Celyad Oncology and Alterome where he is also the audit committee chair.

What is Dominic Piscitelli's net worth?: The estimated net worth of Dominic Piscitelli is at least $995.04 thousand as of December 16th, 2024. Mr. Piscitelli owns 106,764 shares of ORIC Pharmaceuticals stock worth more than $995,040 as of June 8th. This net worth approximation does not reflect any other assets that Mr. Piscitelli may own. Additionally, Mr. Piscitelli receives a salary of $654,740.00 as CFO at ORIC Pharmaceuticals. Learn More about Dominic Piscitelli's net worth.
How old is Dominic Piscitelli?: Mr. Piscitelli is currently 49 years old. There are 7 older executives and no younger executives at ORIC Pharmaceuticals. The oldest executive at ORIC Pharmaceuticals is Dr. Richard A. Heyman Ph.D., Co-Founder, Independent Chairman & Member of Scientific Advisory Board, who is 67 years old. Learn More on Dominic Piscitelli's age.
What is Dominic Piscitelli's salary?: As the CFO of ORIC Pharmaceuticals, Inc., Mr. Piscitelli earns $654,740.00 per year. There are 2 executives that earn more than Mr. Piscitelli. The highest earning executive at ORIC Pharmaceuticals is Dr. Jacob M. Chacko M.B.A., M.D., President, CEO & Director, who commands a salary of $961,000.00 per year. Learn More on Dominic Piscitelli's salary.
How do I contact Dominic Piscitelli?: The corporate mailing address for Mr. Piscitelli and other ORIC Pharmaceuticals executives is 240 E. GRAND AVE. 2ND FLOOR, SOUTH SAN FRANCISCO CA, 94080. ORIC Pharmaceuticals can also be reached via phone at 650-388-5600 and via email at [email protected]. Learn More on Dominic Piscitelli's contact information.
Has Dominic Piscitelli been buying or selling shares of ORIC Pharmaceuticals?: Dominic Piscitelli has not been actively trading shares of ORIC Pharmaceuticals over the course of the past ninety days. Most recently, Dominic Piscitelli sold 8,851 shares of the business's stock in a transaction on Monday, December 16th. The shares were sold at an average price of $8.28, for a transaction totalling $73,286.28. Following the completion of the sale, the chief financial officer now directly owns 106,764 shares of the company's stock, valued at $884,005.92. Learn More on Dominic Piscitelli's trading history.
Who are ORIC Pharmaceuticals' active insiders?: ORIC Pharmaceuticals' insider roster includes Jacob Chacko (CEO), Carl Gordon (Director), Richard Heyman (Director), Pratik Multani (Chief Medical Officer), Dominic Piscitelli (CFO), and Richard Scheller (Director). Learn More on ORIC Pharmaceuticals' active insiders.
Are insiders buying or selling shares of ORIC Pharmaceuticals?: During the last twelve months, insiders at the sold shares 3 times. They sold a total of 42,361 shares worth more than $350,749.08. The most recent insider tranaction occured on December, 16th when CFO Dominic Piscitelli sold 8,851 shares worth more than $73,286.28. Insiders at ORIC Pharmaceuticals own 5.6% of the company. Learn More about insider trades at ORIC Pharmaceuticals.
Information on this page was last updated on 12/16/2024.

Dominic Piscitelli Insider Trading History at ORIC Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/16/2024	Sell	8,851	$8.28	$73,286.28	106,764
3/31/2022	Buy	60,000	$5.36	$321,600.00

Dominic Piscitelli Buying and Selling Activity at ORIC Pharmaceuticals

ORIC Pharmaceuticals Company Overview

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, which is designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer, currently under Phase 1b study; and ORIC-533, an orally bioavailable small molecule inhibitor of CD73, currently under Phase 1b study, being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms, including ORIC-613, an orally bioavailable, highly selective inhibitor of PLK4, in preclinical studies for the treatment of breast cancers. It has a license and collaboration agreement with Voronoi Inc.; a license agreement with Mirati Therapeutics, Inc.; and clinical development collaboration agreement with Pfizer Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.

Today's Range

Now: $9.32

$9.24

$10.07

50 Day Range

MA: $5.68

$4.26

$9.32

2 Week Range

Now: $9.32

$3.90

$14.67

Volume

1,378,970 shs

Average Volume

765,717 shs

Market Capitalization

$662.54 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.49

Dominic Piscitelli Biography and Net Worth

What is Dominic Piscitelli's net worth?

How old is Dominic Piscitelli?

What is Dominic Piscitelli's salary?

How do I contact Dominic Piscitelli?

Has Dominic Piscitelli been buying or selling shares of ORIC Pharmaceuticals?

Who are ORIC Pharmaceuticals' active insiders?

Are insiders buying or selling shares of ORIC Pharmaceuticals?